• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒性休克的发病机制及预防和治疗的潜在策略:最新进展

Pathogenesis and potential strategies for prevention and treatment of septic shock: an update.

作者信息

Glauser M P, Heumann D, Baumgartner J D, Cohen J

机构信息

Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

出版信息

Clin Infect Dis. 1994 Feb;18 Suppl 2:S205-16. doi: 10.1093/clinids/18.supplement_2.s205.

DOI:10.1093/clinids/18.supplement_2.s205
PMID:8148464
Abstract

Septic shock is mediated by complex interactions of cells, cytokines, and humoral pathways. Clinical therapeutic strategies aimed at inhibiting selected pathways have been efficacious in subsets of patients. Experimental studies focusing on the activities of single cytokines have contributed to the understanding of the complex pathophysiology of septic shock. More precise delineation of the roles of each mechanism contributing to pathogenesis will permit the identification of subsets of patients who might benefit from particular therapeutic strategies and will guide the development of additional approaches to prevention and treatment.

摘要

脓毒性休克是由细胞、细胞因子和体液途径的复杂相互作用介导的。旨在抑制特定途径的临床治疗策略在部分患者中已显示出疗效。专注于单一细胞因子活性的实验研究有助于理解脓毒性休克复杂的病理生理学。更精确地描述每种致病机制的作用将有助于识别可能从特定治疗策略中获益的患者亚组,并指导开发更多的预防和治疗方法。

相似文献

1
Pathogenesis and potential strategies for prevention and treatment of septic shock: an update.脓毒性休克的发病机制及预防和治疗的潜在策略:最新进展
Clin Infect Dis. 1994 Feb;18 Suppl 2:S205-16. doi: 10.1093/clinids/18.supplement_2.s205.
2
Current understanding of the pathogenesis of gram-negative shock.目前对革兰氏阴性菌休克发病机制的认识。
Infect Dis Clin North Am. 1991 Dec;5(4):781-91.
3
New strategies in nonantibiotic treatment of gram-negative sepsis.革兰氏阴性菌败血症的非抗生素治疗新策略
Cleve Clin J Med. 1992 Nov-Dec;59(6):608-15. doi: 10.3949/ccjm.59.6.608.
4
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.用于治疗革兰氏阴性菌血症和脓毒性休克的抗脂多糖及抗肿瘤坏死因子/恶病质素抗体
Prog Clin Biol Res. 1991;367:141-59.
5
[Monoclonal antibodies in the treatment of septic shock].
Med Clin (Barc). 1992 Dec 12;99(20):778-80.
6
[The application of molecular biology to anti-endotoxin therapies].
Nihon Geka Gakkai Zasshi. 2003 Jul;104(7):523-6.
7
Immunologic therapy for ARDS, septic shock, and multiple-organ failure.针对急性呼吸窘迫综合征、感染性休克和多器官功能衰竭的免疫治疗。
Chest. 1993 Mar;103(3):932-43. doi: 10.1378/chest.103.3.932.
8
Possibilities of immunoprophylaxis and immunotherapy in gut-derived infectious-toxic shock (GITS).肠道源性感染性中毒性休克(GITS)的免疫预防和免疫治疗可能性。
Curr Stud Hematol Blood Transfus. 1992(59):301-23. doi: 10.1159/000429615.
9
[Cytokines and septic shock. New perspectives on its treatment].[细胞因子与脓毒性休克。其治疗的新观点]
An Med Interna. 1993 Dec;10(12):573-5.
10
Therapies for sepsis. Emerging therapies for sepsis and septic shock.脓毒症的治疗方法。脓毒症和脓毒性休克的新兴治疗方法。
West J Med. 1997 Mar;166(3):195-200.

引用本文的文献

1
Recent Advances in Lipopolysaccharide Recognition Systems.脂多糖识别系统的最新进展。
Int J Mol Sci. 2020 Jan 7;21(2):379. doi: 10.3390/ijms21020379.
2
Hypertonic saline solution drives neutrophil from bystander organ to infectious site in polymicrobial sepsis: a cecal ligation and puncture model.高渗盐水溶液促使多微生物脓毒症中旁观器官的中性粒细胞向感染部位迁移:盲肠结扎和穿刺模型。
PLoS One. 2013 Sep 17;8(9):e74369. doi: 10.1371/journal.pone.0074369. eCollection 2013.
3
p-Cymene modulates in vitro and in vivo cytokine production by inhibiting MAPK and NF-κB activation.
对-香芹酚通过抑制 MAPK 和 NF-κB 的激活来调节细胞因子的体外和体内产生。
Inflammation. 2013 Jun;36(3):529-37. doi: 10.1007/s10753-012-9574-y.
4
Comparison of inflammation, organ damage, and oxidant stress induced by Salmonella enterica serovar Muenchen flagellin and serovar Enteritidis lipopolysaccharide.肠炎沙门氏菌慕尼黑血清型鞭毛蛋白和肠炎血清型脂多糖诱导的炎症、器官损伤及氧化应激的比较
Infect Immun. 2002 Jan;70(1):192-8. doi: 10.1128/IAI.70.1.192-198.2002.
5
Characterization of a monoclonal antibody that binds to an epitope on soluble bacterial peptidoglycan fragments.一种与可溶性细菌肽聚糖片段上的表位结合的单克隆抗体的特性分析。
Clin Diagn Lab Immunol. 2001 May;8(3):647-51. doi: 10.1128/CDLI.8.3.647-651.2001.
6
E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide.E5531,一种合成的无毒脂多糖A衍生物,可阻断脂多糖的免疫生物学活性。
Br J Pharmacol. 1999 Jun;127(4):853-62. doi: 10.1038/sj.bjp.0702596.
7
Protective effect of pentoxifylline plus thalidomide against septic shock in mice.己酮可可碱联合沙利度胺对小鼠脓毒症休克的保护作用
Int J Exp Pathol. 1999 Feb;80(1):11-6. doi: 10.1046/j.1365-2613.1999.00085.x.
8
Treatment of sepsis: past and future avenues.脓毒症的治疗:过去与未来的途径
Drugs. 1999 Feb;57(2):127-32. doi: 10.2165/00003495-199957020-00001.
9
Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4).内毒素耐受小鼠的Toll样受体4(Tlr4)存在突变。
J Exp Med. 1999 Feb 15;189(4):615-25. doi: 10.1084/jem.189.4.615.
10
Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin.细胞溶解性淋巴细胞产生的一种肽——NK溶素与内毒素的相互作用。
Infect Immun. 1999 Jan;67(1):201-5. doi: 10.1128/IAI.67.1.201-205.1999.